Echinacea and trypanasomatid parasite interactions: Growth-inhibitory and anti-inflammatory effects of Echinacea

Pharmaceutical Biology

Volumn 48, Issue 9, 2010, Pages 1047-1052

  Canlas, Judith ^a   Hudson, James B ^a   Sharma, Manju ^a   Nandan, Devki ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

IL 6; IL 8; Leishmania sp.; Pro inflammatory cytokines; Trypanosoma brucei

Indexed keywords

ALCOHOL; AMIDE; CAFFEIC ACID DERIVATIVE; ECHINACEA ANGUSTIFOLIA EXTRACT; ECHINACEA EXTRACT; ECHINACEA PURPUREA EXTRACT; ECHINAFORCE; INTERLEUKIN 6; INTERLEUKIN 8; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; BRONCHUS MUCOSA; CELL CULTURE; CHEMICAL COMPOSITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG POTENCY; ECHINACEA; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; NONHUMAN; PLANT ROOT; SKIN FIBROBLAST; TRYPANOSOMA BRUCEI;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPROTOZOAL AGENTS; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ECHINACEA; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; NONPRESCRIPTION DRUGS; PHYTOTHERAPY; PLANT EXTRACTS; SKIN; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI;

ASTERACEAE; ECHINACEA (ASTERACEAE); ECHINACEA PURPUREA; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIA SP.; TRYPANOSOMA BRUCEI; TRYPANOSOMATIDAE;

EID: 77956022262     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880200903483468     Document Type: Article

References (18)

1. Atawodi SE, Bulus T, Ibrahim S, Ameh DA, Nok AJ, Mamman M, Galadima M (2003): In vitro trypanocidal effect of methanolic extract of some Nigerian savannah plants. Afr J Biotechnol 2: 317-321.
2. Barnes J, Anderson LA, Gibbons S, Phillipson JD (2005): Echinacea species (Echinacea angustifolia (DC.) Hell. Echinacea pallida (Nutt.) Nutt. Echinacea purpurea (L.) Moench.: A review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol 57: 929-954.
3. Barrett B (2003): Medicinal properties of Echinacea: A critical review. Phytomedicine 10: 66-86.
4. Bauer R (1998): Echinacea: Biological effects and active principals. Phytomedicines of Europe: Chemistry and biological activity, in: Lawson LD, Bauer R, eds, ACS symposium series 691. Washington DC, American Chemical Society, pp. 140-157.
5. Binns SE, Livesey JF, Arnason JT, Baum BR (2002): Phytochemical variation in Echinacea from roots and flower heads of wild and cultivated populations. J Agric Food Chem 50: 3673-3687.
6. Braga FG, Bouzada MLM, Fabri RL, Matos MO, Moreira FO, Scio E, Coimbra ES (2007): Antileishmanial and antifungal activity of plants used in traditional medicine in Brazil. J Ethnopharmacol 111: 396-402.
7. Desrivot J, Waikedre J, Cabalion P, Herrenknecht C, Bories C, Hocquemiller R, Fournet A (2007): Antiparasitic activity of some New Caledonian medicinal plants. J Ethnopharmacol 112: 7-12.
8. Gamboa-Leon MR, Aranda-Gonzalex I, Mut-Martin M, Garcia MR, Dumonteil E (2007): In vivo and in vitro control of Leishmania mexicana due to garlic-induced NO production. Scand J Immunol 66: 508-514.
9. Hay A-E, Merza J, Landreau A, Litaudon M, Pagniez F, Pape PL, Richomme P (2008): Antileishmanial polyphenols from Garcinia vieillardii. Fitoterapia 79: 42-46.
10. Matthias A, Banbury L, Bone KM, Leach DN, Lehmann RP (2008): Echinacea alkylamides modulate induced immune responses in T-cells. Fitoterapia 79: 53-58.
11. Sharma M, Arnason JT, Burt A, Hudson JB (2006): Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells. Phytother Res 20: 147-152.
12. Sharma M, Schoop R, Hudson JB (2008): Echinacea as an antiinflammatory agent: The influence of physiologically relevant parameters. Phytotherapy Res 23: 863-867.
13. Sharma M, Anderson S, Schoop R, Hudson JB (2009): Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Res 83: 165-170.
14. Vimalanathan S, Kang L, Treyvaud Amiguet V, Livesey J, Arnason JT, Hudson J (2005): Echinacea purpurea aerial parts contain multiple antiviral compounds. Pharm Biol 43: 740-745.
15. Vimalanathan S, Arnason JT, Hudson JB (2009): Anti-inflammatory activities of Echinacea extracts do not correlate with traditional marker components. Pharm Biol 47: 430-435.
16. Vohra S, Adams D, Hudson JB, Moore JA, Vimalanathan S, Sharma M, Burt AJ, Lamont E, Lacaze N, Arnason JT, Lee TDG (2009): Selection of natural health products for clinical trials: A preclinical template. Can J Physiol Pharmacol 87: 371-378.
17. WHO (World Health Organization) (2008a): Leishmaniasis. Available At http://www.who.int/leishmaniasis/disease-epidemiology/ en/index.html (accessed April 28, 2008).
18. WHO (World Health Organization) (2008b) African trypanosomiasis (sleeping sickness). Available at http://www.who.int/mediacentre/ factsheets/fs259/en/ (accessed April 28, 2008).